Found 8 matching trials
A One-year Randomized Controlled Trial Evaluating the Impact of Pioglitazone Versus Linagliptin on Bone Turnover Markers PHASE4 Diabetes mellitus is a common disease with much impact on human's health an...
Show More Location
Multiple Locations
Learn More & Join Trial
Effects of Glucose Lowering Agents in South Asian Women With Impaired Glucose Tolerance or Impaired Fasting Glucose PHASE2 This study will test the effect of four common oral anti-diabetic agents on...
Show More Location
Oslo University Hospital, Aker Hospital
Learn More & Join Trial
Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DM PHASE3 The objective of the current study is to investigate the safety and tolerab...
Show More Location
1218.40.10003 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
30 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+30 and 5+45 mg) qd Versus Respective Monotherapies, Followed by a Comparison of 5mg+30mg and 5mg+45mg Versus Respective Monotherapies in Type 2 Diabetes for up to 54 Weeks PHASE3 The primary objective is to demonstrate superior glycaemic control (HbA1c r...
Show More Location
1264.3.01026 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Bioequivalence of a Fixed Dose Combination Tablet Linagliptin/Pioglitazone Compared With Its Mono-components PHASE1 The objective of the current study is to establish the bioequivalence of li...
Show More Location
1264.14.1 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
New Triple Therapy in Newly Diagnosed Type 2 Diabetes PHASE3 The goal of this clinical trial is to learn the efficany of combination the...
Show More Location
The First Affiliated Hospital of Sun Yat-sen University
Learn More & Join Trial
Efficacy vs Placebo as Initial Combination Therapy With Pioglitazone PHASE3 The objective of the current study is to investigate the efficacy, safety a...
Show More Location
1218.15.43004 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
New Triple Combination Therapy in Newly Diagnosed Type 2 Diabetes PHASE3 The goal of this clinical trial is to learn the efficacy of combination the...
Show More Location
The First Affiliated Hospital of Sun Yat-sen University
Learn More & Join Trial